Literature DB >> 28077615

Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough?

Scott C Bell1,2, Patrick A Flume3.   

Abstract

Entities:  

Keywords:  Cystic Fibrosis; Respiratory Infection

Mesh：

Substances：

Year:  2017        PMID： 28077615     DOI： 10.1136/thoraxjnl-2016-209605

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  3 in total

1.  Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study.

Authors:  Daniela Dolce; Stella Neri; Laura Grisotto; Silvia Campana; Novella Ravenni; Francesca Miselli; Erica Camera; Lucia Zavataro; Cesare Braggion; Ersilia V Fiscarelli; Vincenzina Lucidi; Lisa Cariani; Daniela Girelli; Nadia Faelli; Carla Colombo; Cristina Lucanto; Mariangela Lombardo; Giuseppe Magazzù; Antonella Tosco; Valeria Raia; Serena Manara; Edoardo Pasolli; Federica Armanini; Nicola Segata; Annibale Biggeri; Giovanni Taccetti
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

2.  "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.

Authors:  Peter H Gilligan; Damian G Downey; J Stuart Elborn; Patrick A Flume; Sebastian Funk; Deirdre Gilpin; Timothy J Kidd; John McCaughan; B Cherie Millar; Philip G Murphy; Jacqueline C Rendall; Michael M Tunney; John E Moore
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

3.  Factors Influencing Lung Function in Patients with Cystic Fibrosis in Western Romania.

Authors:  Mihaela Dediu; Ioana Mihaiela Ciuca; Monica Steluta Marc; Estera Boeriu; Liviu Laurentiu Pop
Journal:  J Multidiscip Healthc       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.